CINECA IRIS Institutional Research Information System

PRATESI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.704
AS - Asia 3.474
EU - Europa 2.338
SA - Sud America 813
AF - Africa 207
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 11.545
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.609
CN - Cina 1.101
IT - Italia 1.079
SG - Singapore 1.054
BR - Brasile 651
HK - Hong Kong 578
VN - Vietnam 304
SE - Svezia 277
DE - Germania 194
BG - Bulgaria 147
FI - Finlandia 140
CI - Costa d'Avorio 128
KR - Corea 123
AT - Austria 94
RU - Federazione Russa 92
FR - Francia 74
AR - Argentina 70
GB - Regno Unito 62
IN - India 59
TR - Turchia 54
CA - Canada 43
JP - Giappone 39
EC - Ecuador 28
IQ - Iraq 27
PL - Polonia 27
SN - Senegal 27
BD - Bangladesh 26
MX - Messico 26
ES - Italia 25
CH - Svizzera 24
CZ - Repubblica Ceca 21
ID - Indonesia 18
NL - Olanda 17
PK - Pakistan 13
PY - Paraguay 13
UA - Ucraina 12
BE - Belgio 11
CO - Colombia 11
UZ - Uzbekistan 11
MA - Marocco 10
VE - Venezuela 10
CL - Cile 9
ZA - Sudafrica 9
NG - Nigeria 8
UY - Uruguay 8
AL - Albania 7
BO - Bolivia 7
KE - Kenya 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
SA - Arabia Saudita 6
IL - Israele 5
JO - Giordania 5
OM - Oman 5
PE - Perù 5
TN - Tunisia 5
TW - Taiwan 5
AZ - Azerbaigian 4
DZ - Algeria 4
GR - Grecia 4
HN - Honduras 4
IE - Irlanda 4
KZ - Kazakistan 4
RO - Romania 4
RS - Serbia 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EU - Europa 3
IR - Iran 3
JM - Giamaica 3
KW - Kuwait 3
PA - Panama 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AM - Armenia 2
AU - Australia 2
BB - Barbados 2
BS - Bahamas 2
EE - Estonia 2
HU - Ungheria 2
MY - Malesia 2
NP - Nepal 2
QA - Qatar 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
KG - Kirghizistan 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
Totale 11.539
Salva come PNG Salva come JPEG
Città #
Ashburn 634
Hong Kong 576
Singapore 555
Shanghai 520
Fairfield 437
Santa Clara 433
Dallas 364
Woodbridge 274
Milan 257
Chandler 193
Houston 193
Seattle 191
Hefei 172
Wilmington 165
Cambridge 161
Sofia 147
Beijing 137
New York 137
Abidjan 128
San Jose 125
Seoul 121
Livorno 116
Ann Arbor 109
Helsinki 107
Pisa 103
Los Angeles 102
Boardman 93
Ho Chi Minh City 88
Vienna 80
Serra 78
Princeton 76
Florence 68
Bremen 61
Munich 61
Lawrence 58
São Paulo 56
Medford 52
Rome 46
Hanoi 42
Istanbul 42
Redondo Beach 35
Frankfurt am Main 31
Tokyo 30
Buffalo 29
Council Bluffs 29
Dakar 27
San Diego 27
London 26
Rio de Janeiro 24
Dong Ket 22
Turku 20
Ogden 19
Ottawa 19
Vicopisano 19
Bern 18
Fuzhou 18
Kent 18
Porto Alegre 17
Nuremberg 16
Warsaw 16
Fort Wayne 15
San Giuliano Terme 15
Brno 14
Salvador 14
Paris 13
Boulder 12
Chennai 12
Des Moines 12
Washington 12
Belo Horizonte 11
Da Nang 11
Guayaquil 11
Norwalk 11
Tashkent 11
Wuhan 11
Brussels 10
Cascina 10
Curitiba 10
Mexico City 10
Quanzhou 10
Trento 10
Baghdad 9
Brasília 9
Buenos Aires 9
Nanjing 9
Pune 9
Betim 8
Casarza Ligure 8
Chicago 8
Jacksonville 8
Lappeenranta 8
Marseille 8
Montevideo 8
Quito 8
Santo André 8
Turin 8
Amsterdam 7
Biên Hòa 7
Boston 7
Denver 7
Totale 8.216
Salva come PNG Salva come JPEG
Nome #
Alkyne Functionalization of a Photoactivated Ruthenium Polypyridyl Complex for Click-Enabled Serum Albumin Interaction Studies 428
New copper(II)/cyclic tetrapeptide system that easily oxidizes to copper(III) under atmospheric oxygen 238
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 225
Photocytotoxic Pt(iv) complexes as prospective anticancer agents 223
Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells 200
When ferrocene and diiron organometallics meet: triiron vinyliminium complexes exhibit strong cytotoxicity and cancer cell selectivity 198
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 193
Neurotrophic Activity and Its Modulation by Zinc Ion of a Dimeric Peptide Mimicking the Brain-Derived Neurotrophic Factor N-Terminal Region 186
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study 181
Mass spectrometry and metallomics: A general protocol to assess stability of metallodrug-protein adducts in bottom-up MS experiments 173
Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent 170
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 169
Antiproliferative properties and biomolecular interactions of three Pd(II) and Pt(II) complexes 166
New gold carbene complexes as candidate anticancer agents 166
An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies 165
Reactions of medicinally relevant gold compounds with the C-terminal motif of thioredoxin reductase elucidated by MS analysis 162
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 161
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 157
A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies 156
Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues 154
Design and Solid Phase Synthesis of New DOTA Conjugated (+)-Biotin Dimers Planned to Develop Molecular Weight-Tuned Avidin Oligomers 152
Biotin derivatives carrying two chelating DOTA units. Synthesis, in vitro evaluation of biotinidases resistance, avidin binding, and radiolabeling tests 151
Role of the (pseudo)halido ligand in ruthenium(ii): p -cymene a-amino acid complexes in speciation, protein reactivity and cytotoxicity 151
Ruthenium arene complexes with triphenylphosphane ligands: Cytotoxicity towards pancreatic cancer cells, interaction with model proteins, and effect of ethacrynic acid substitution 148
A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes 147
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 145
The cisplatin/serum albumin system: A reappraisal 143
Synthesis, Characterization and Photoactivation Studies on the Novel Pt(IV)-Based [Pt(OCOCH3)3(phterpy)] Complex 143
Insights on the mechanism of thioredoxin reductase inhibition by Gold N-heterocyclic carbene compounds using the synthetic linear Selenocysteine containing C-terminal peptide hTrxR(488-499): An ESI-MS investigation 142
The NAMI A-human ferritin system: A biophysical characterization 141
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with a L-alanyl-based ligand 140
Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues 138
ESI MS studies highlight the selective interaction of Auranofin with protein free thiols 138
Reactions of Auranofin and Its Pseudohalide Derivatives with Serum Albumin Investigated through ESI-Q-TOF MS 135
The New Pyrimido-indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects Without Cardio-toxicity 135
Thermodynamic Evaluation of the Interactions between Anticancer Pt(II) Complexes and Model Proteins 135
Protein metalation by two structurally related gold(I) carbene complexes: An ESI MS study 132
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study 131
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target Biomolecules 130
Structural Characterization of a Gold/Serum Albumin Complex 128
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 128
Structure of a new stable Cu(III)/cyclopeptide complex by Cu K-edge XAS study 124
Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation 123
Impact of ring size on the copper(II) coordination abilities of cyclic tetrapeptides 122
Mass spectrometry and metallomics: stability and binding site location in the Cyt c-CDDP model system 122
Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments 120
Exploiting the Chemical Diversity of Metal Compounds as a Source of Novel Anti-COVID-19 Drugs 119
Synthesis, Chemical Characterization, and Biological Evaluation of Hydrophilic Gold(I) and Silver(I) N-Heterocyclic Carbenes as Potential Anticancer Agents 119
ESI–MS studies of the reactions of novel platinum(II) complexes containing O,O′-chelated acetylacetonate and sulfur ligands with selected model proteins 119
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 117
Dioxygen oxidation Cu(II) → Cu(III) in the copper complex of cyclo (Lys- d His-βAla-His): A case study by EXAFS and XANES approach 116
Mass Spectrometry and Metallomics: binding site location in the Cyt c-CDDP model system 116
Description of a Non-Canonical AsPt Blue Species Originating from the Aerobic Oxidation of AP-1 in Aqueous Solution 115
Ru(CO)x-core complexes with selected azoles: Synthesis, X-ray structure, spectroscopy, DFT analysis and evaluation of cytotoxic activity against human cancer cells 115
Evaluation of Auranofin Loading within Ferritin Nanocages 114
Short-chain oligopeptides with copper(II) binding properties: the impact of specific structural modifications on the copper(II) coordination abilities 113
Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety 111
Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs 110
Reactions of medicinal gold(III) compounds with proteins and peptides explored by electrospray ionization mass spectrometry and complementary biophysical methods 110
Exploring the interaction between a fluorescent Ag(I)-biscarbene complex and non-canonical DNA structures: a multi-technique investigation 110
Computationally enhanced X-ray diffraction analysis of a gold(III) complex interacting with the human telomeric DNA G-quadruplex. Unravelling non-unique ligand positioning 109
The choice of μ-vinyliminium ligand substituents is key to optimize the antiproliferative activity of related diiron complexes 108
Strategies for the improvement of metal-based chemotherapeutic treatments 108
An unprecedented palladium-arsenic catalytic cycle for nitriles hydration 107
DOTA-Derivatives of Octreotide Dicarba-Analogs with High Affinity for Somatostatin sst2,5 Receptors 106
Protein interactions of dirhodium tetraacetate: a structural study 105
Native mass spectrometry of human carbonic anhydrase I and its inhibitor complexes 105
Pd(II)/1,10-phenanthroline complexes bearing arene ligands: On the role of N- vs O-coordination to tune their cellular activity and binding ability towards DNA and RNA 104
Synthesis of dicarba-cyclooctapeptide Somatostatin analogs by conventional and MW-assisted RCM: A study about the impact of the configuration at Cα of selected amino acids 103
Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth - An Investigation of the Activation Mechanism and Their Nanoformulation 99
Arsenoplatin-ferritin nanocage: Structure and cytotoxicity 99
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 98
Iron Binding in the Ferroxidase Site of Human Mitochondrial Ferritin 96
Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles 96
Cytotoxic auranofin analogues bearing phosphine, arsine and stibine ligands: A study on the possible role of the ligand on the biological activity 91
Reevaluating the Mechanistic Insights of α-TOS-Bearing Pt(IV) Anticancer Complexes: A New Perspective from a More In-Depth Knowledge 90
A new stable Copper(III)/Cyclopeptide complex: structural characterization by XANES and EXAFS studies 88
Non‐medical applications of inorganic medicines. A switch based on mechanistic knowledge 87
Proteomics as a tool to disclose the cellular and molecular mechanisms of selected anticancer gold compounds 87
Trans-Pd(II) complexes: A different approach for the development of promising anticancer drugs 84
A biophysical study of the interactions of palladium(II), platinum(II) and gold(III) complexes of aminopyridyl-2,2'-bipyridine ligands with RNAs and other nucleic acid structures 83
A new stable Copper(III)/Cyclopeptide complex: structural characterization by XANES and EXAFS studies 82
Direct detection of iron clusters in L ferritins through ESI-MS experiments 75
null 71
Editorial: The Golden Future in Medicinal Chemistry: Perspectives and Resources From Old and New Gold-Based Drug Candidates 70
Structure of a New Stable Cu(III)/Cyclopeptide Complex by Cu K-Edge XAS Study 67
null 66
Anticancer diiron vinyliminium complexes: A structure– activity relationship study 59
null 55
Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin Adduct 54
Hydrophobic gold nanoparticles coupled with fluorescent dyes: A smart tool for optoelectronic applications 51
Is the Next Cisplatin Already in Our Laboratory? 51
Procedimento catalitico per la preparazione di ammidi 50
Editorial: Spotlight on Europe - chemical sciences 2023 48
null 41
Redefining platinum(IV) chemotherapy: α-tocopherol succinate functionalization and nanoparticle encapsulation to improve cisplatin- and oxaliplatin-based therapies 36
Oxaliplatin inhibits angiogenin proliferative and cell migration effects in prostate cancer cells 34
null 26
Mechanistic Fingerprints from Chloride to Iodide: Halide vs. Ammonia Release in Platinum Anticancer Complexes 11
Totale 12.019
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.772
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021440 0 0 0 0 0 0 22 50 131 81 51 105
2021/2022724 17 23 11 35 138 111 46 26 72 20 67 158
2022/20231.275 130 120 92 97 73 117 35 59 418 39 48 47
2023/20241.063 115 106 144 77 150 161 71 26 19 22 73 99
2024/20253.724 21 100 18 159 305 326 750 161 378 430 394 682
2025/20263.041 266 581 607 693 324 311 259 0 0 0 0 0
Totale 12.019